Onyia Jude (CIK 0001894425)

Latest company ownership

Role: Chief Scientific Officer
Shares held
4,426
Last filed at
Dec 2, 2025
Confidence Score
32.8
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 29, 2025 Dec 2, 2025 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 40.0 -2,248 -12.40% $342.1K
Jul 9, 2025 Jul 11, 2025 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 3.8 -59,819 -76.58% $7.8M
Jul 2, 2025 Jul 7, 2025 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 5.0 -20,362 -52.68% $2.6M
Feb 13, 2025 Feb 14, 2025 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 26.3 -2,879 -7.61% $336.2K
Jan 31, 2025 Feb 4, 2025 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 51.3 -126 -0.80% $19.3K
Nov 29, 2024 Dec 3, 2024 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 22.5 -2,331 -13.11% $294.4K
Feb 13, 2024 Feb 15, 2024 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 28.8 -1,432 -9.84% $190.4K
Jan 31, 2024 Feb 2, 2024 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 48.8 -126 -1.05% $17.9K
Nov 29, 2023 Dec 1, 2023 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 17.5 -2,331 -16.58% $264.7K
Aug 21, 2023 Aug 23, 2023 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 12.5 -3,198 -24.91% $343.4K
Feb 7, 2023 Feb 8, 2023 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 7.5 -4,508 -40.86% $461.2K
Jan 31, 2023 Feb 2, 2023 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 41.3 -126 -4.84% $13.7K
Nov 29, 2022 Dec 1, 2022 NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Sell 7.5 -2,331 -49.63% $284.2K